1308814-99-4

Basic information

• Product Name: ethyl 1-(4-aminophenyl)cyclopropanecarboxylate
• Synonyms: ethyl 1-(4-aminophenyl)cyclopropanecarboxylate
• CAS NO: 1308814-99-4
• Molecular Weight: 205.257
• Mol File: 1308814-99-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: ethyl 1-(4-aminophenyl)cyclopropanecarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 1-(4-aminophenyl)cyclopropanecarboxylate(1308814-99-4)
• EPA Substance Registry System: ethyl 1-(4-aminophenyl)cyclopropanecarboxylate(1308814-99-4)

Safety Data

• Hazardous Substances Data: 1308814-99-4(Hazardous Substances Data)

Upstream product

• 5445-26-1 ETHYL 4-NITROPHENYLACETATE 
• 408328-42-7 1-(4-nitrophenyl)-1-cyclopropylcarbonitrile 
• 935-44-4 1-cyano-1-phenylcyclopropane 
• 140-29-4 phenylacetonitrile 
• 1308814-98-3 ethyl 1-(4-nitrophenyl)cyclopropanecarboxylate 

Downstream Products

• 1308815-10-2 ethyl 1-(4-(((benzyloxy)carbonyl)amino)phenyl)cyclopropanecarboxylate 
• 1308815-00-0 ethyl 1-(4-((3-(1,3-dioxoisoindolin-2-yl)-2-hydroxypropyl)amino)phenyl)cyclopropanecarboxylate 
• 1308815-01-1 ethyl 1-(4-(5-((1,3-dioxoisoindolin-2-yl)methyl)-2-oxooxazolidin-3-yl)phenyl)cyclopropanecarboxylate 
• 1308815-03-3 ethyl 1-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)cyclopropanecarboxylate 
• 1308815-04-4 ethyl 1-[4-(5-{[(5-chlorothiophene-2-carbonyl)amino]methyl}-2-oxo-oxazolidin-3-yl)phenyl]cyclopropanecarboxylate 
• 1308815-08-8 5-chloro-N-((3-(4-(1-(hydroxymethyl)cyclopropyl)phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide 
• 1308815-09-9 N-((3-(4-(1-(bromomethyl)cyclopropyl)phenyl)-2-oxooxazolidin-5-yl)methyl)-5-chlorothiophene-2-carboxamide 
• 1308814-51-8 5-chloro-N-((3-(4-(1-((dimethylamino)methyl)cyclopropyl)phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide 

Relevant articles and documents

COMPOUNDS AND METHODS FOR INHIBITING CYP26 ENZYMES

Compounds described herein are inhibitors of retinoic acid inducible P450 (CYP26) enzymes, and are useful for treating diseases that are responsive to retinoids. Certain compounds have retinoid activity, are resistant to CYP26-mediated catabolism, and are used for treating diseases that are responsive to retinoids.

NOVEL ANTITHROMBOTIC AGENTS

The present invention relates to novel derivatives of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.